Advanced search
Publication Cover
Molecular and Cellular Biology Volume 21, 2001 - Issue 8
Submit an article Journal homepage
36
Views
99
CrossRef citations to date
0
Altmetric
Cell Growth and Development

S and G2 Phase Roles for Cdk2 Revealed by Inducible Expression of a Dominant-Negative Mutant in Human Cells

Bing Hu1 Departments of Medicine;2 Genetics;3 Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania
,
Jayashree Mitra1 Departments of Medicine;2 Genetics;3 Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania
,
Sander van den Heuvel4 Massachusetts General Hospital Cancer Center, Charlestown, Massachusetts
&
Greg H. Enders1 Departments of Medicine;2 Genetics;3 Cancer Center, University of Pennsylvania, Philadelphia, PennsylvaniaCorrespondence[email protected]
Pages 2755-2766 | Received 08 Nov 2000, Accepted 17 Jan 2001, Published online: 28 Mar 2023

Citations (99)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (9)

Komal Jhaveri, Howard A Burris 3rd, Timothy A Yap, Erika Hamilton, Hope S Rugo, Jonathan W Goldman, Stephen Dann, Feng Liu, Gilbert Y Wong, Heike Krupka & Geoffrey I Shapiro. (2021) The evolution of cyclin dependent kinase inhibitors in the treatment of cancer. Expert Review of Anticancer Therapy 21:10, pages 1105-1124.
Read now
Jianzhong Chen, Laixue Pang, Wei Wang, Lifei Wang, John Z. H. Zhang & Tong Zhu. (2020) Decoding molecular mechanism of inhibitor bindings to CDK2 using molecular dynamics simulations and binding free energy calculations. Journal of Biomolecular Structure and Dynamics 38:4, pages 985-996.
Read now
Yuanhong Liao, Jianya Ling, Guoying Zhang, Fengjun Liu, Shengce Tao, Zeguang Han, Saijuan Chen, Zhu Chen & Huangying Le. (2015) Cordycepin induces cell cycle arrest and apoptosis by inducing DNA damage and up-regulation of p53 in Leukemia cells. Cell Cycle 14:5, pages 761-771.
Read now
James S. Blachly & John C. Byrd. (2013) Emerging drug profile: cyclin-dependent kinase inhibitors. Leukemia & Lymphoma 54:10, pages 2133-2143.
Read now
Frederick Luk, Yan Yu, William R. Walsh & Jia-Lin Yang. (2011) IGF1R-Targeted Therapy and Its Enhancement of Doxorubicin Chemosensitivity in Human Osteosarcoma Cell Lines. Cancer Investigation 29:8, pages 521-532.
Read now
Changqing Li, Mark Andrake, Roland Dunbrack & Greg H. Enders. (2010) A Bifunctional Regulatory Element in Human Somatic Wee1 Mediates Cyclin A/Cdk2 Binding and Crm1-Dependent Nuclear Export. Molecular and Cellular Biology 30:1, pages 116-130.
Read now
Cheen Fei Chin & Foong May Yeong. (2010) Safeguarding Entry into Mitosis: the Antephase Checkpoint. Molecular and Cellular Biology 30:1, pages 22-32.
Read now
Bipin C. Dash & Wafik S. El-Deiry. (2005) Phosphorylation of p21 in G2/M Promotes Cyclin B-Cdc2 Kinase Activity. Molecular and Cellular Biology 25:8, pages 3364-3387.
Read now
Yonghong Zhu, Carmen Alvarez, Ronald Doll, Hirokazu Kurata, Xiao Min Schebye, David Parry & Emma Lees. (2004) Intra-S-Phase Checkpoint Activation by Direct CDK2 Inhibition. Molecular and Cellular Biology 24:14, pages 6268-6277.
Read now

Articles from other publishers (90)

Elizabeth Proaño-Pérez, Laia Ollé, Yanru Guo, Cristina Aparicio, Mario Guerrero, Rosa Muñoz-Cano & Margarita Martin. (2023) MITF Downregulation Induces Death in Human Mast Cell Leukemia Cells and Impairs IgE-Dependent Degranulation. International Journal of Molecular Sciences 24:4, pages 3515.
Crossref
Elizabeth Proaño-Pérez, Eva Serrano-Candelas, Alfonso García-Valverde, Jordi Rosell, David Gómez-Peregrina, Arnau Navinés-Ferrer, Mario Guerrero, César Serrano & Margarita Martín. (2022) The microphthalmia-associated transcription factor is involved in gastrointestinal stromal tumor growth. Cancer Gene Therapy 30:2, pages 245-255.
Crossref
Elizabeth Proaño-Pérez, Eva Serrano-Candelas, Cindy Mancia, Arnau Navinés-Ferrer, Mario Guerrero & Margarita Martin. (2022) SH3BP2 Silencing Increases miRNAs Targeting ETV1 and Microphthalmia-Associated Transcription Factor, Decreasing the Proliferation of Gastrointestinal Stromal Tumors. Cancers 14:24, pages 6198.
Crossref
Fanxiang Yin, Ran Zhao, Dhilli Rao Gorja, Xiaorong Fu, Ning Lu, Hai Huang, Beibei Xu, Hanyong Chen, Jung-Hyun Shim, Kangdong Liu, Zhi Li, Kyle Vaughn Laster, Zigang Dong & Mee-Hyun Lee. (2022) Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo. Acta Pharmaceutica Sinica B 12:11, pages 4122-4137.
Crossref
Lei Zheng, Yunpeng Yang, Jingxiao Bao, Liping He, Yifei Qi & John Z. H. Zhang. (2022) Discovery of novel inhibitors of CDK2 using docking and physics‐based binding free energy calculation. Chemical Biology & Drug Design 99:5, pages 662-673.
Crossref
Ewelina Stelcer, Hanna Komarowska, Karol Jopek, Agnieszka Żok, Dariusz Iżycki, Agnieszka Malińska, Beata Szczepaniak, Zhanat Komekbai, Marek Karczewski, Tomasz Wierzbicki, Wiktoria Suchorska, Marek Ruchała & Marcin Ruciński. (2022) Biological response of adrenal carcinoma and melanoma cells to mitotane treatment. Oncology Letters 23:4.
Crossref
Lenka Horníková, Kateřina Bruštíková, Sandra Huérfano & Jitka Forstová. (2022) Nuclear Cytoskeleton in Virus Infection. International Journal of Molecular Sciences 23:1, pages 578.
Crossref
Colleen E. Quaas & David T. Long. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology 469 492 .
Sushma Maharjan, Yun-Suk Kwon, Min-Gu Lee, Kyu-Shik Lee & Kyung-Soo Nam. (2021) Cell cycle arrest-mediated cell death by morin in MDA-MB-231 triple-negative breast cancer cells. Pharmacological Reports 73:5, pages 1315-1327.
Crossref
Ghaneya S. Hassan, Hanan H. Georgey, Esraa Z. Mohammed, Riham F. George, Walaa R. Mahmoud & Farghaly A. Omar. (2021) Mechanistic selectivity investigation and 2D-QSAR study of some new antiproliferative pyrazoles and pyrazolopyridines as potential CDK2 inhibitors. European Journal of Medicinal Chemistry 218, pages 113389.
Crossref
Vidyasagar Koduri, Leslie Duplaquet, Benjamin L. Lampson, Adam C. Wang, Amin H. SabetMette IshoeyJoshiawa Paulk, Mingxing Teng, Isaac S. Harris, Jennifer E. Endress, Xiaoxi LiuEthan DasilvaJoao A. Paulo, Kimberly J. BriggsJohn G. Doench, Christopher J. Ott, Tinghu ZhangKatherine A. Donovan, Eric S. Fischer, Steven P. Gygi, Nathanael S. Gray, James Bradner, Jeffrey A. Medin, Sara J. BuhrlageMatthew G. Oser & William G. KaelinJr.Jr.. (2021) Targeting oncoproteins with a positive selection assay for protein degraders. Science Advances 7:6.
Crossref
Małgorzata Sekuła-Stryjewska, Sylwia Noga, Monika Dźwigońska, Edyta Adamczyk, Elżbieta Karnas, Joanna Jagiełło, Agnieszka Szkaradek, Paulina Chytrosz, Dariusz Boruczkowski, Zbigniew Madeja, Andrzej Kotarba, Ludwika Lipińska & Ewa K. Zuba-Surma. (2021) Graphene-based materials enhance cardiomyogenic and angiogenic differentiation capacity of human mesenchymal stem cells in vitro – Focus on cardiac tissue regeneration. Materials Science and Engineering: C 119, pages 111614.
Crossref
Eun-Jin An, Yumi Kim, Seung-Hyeon Lee, Hyun Min Ko, Won-Seok Chung & Hyeung-Jin Jang. (2020) Anti-Cancer Potential of Oxialis obtriangulata in Pancreatic Cancer Cell through Regulation of the ERK/Src/STAT3-Mediated Pathway. Molecules 25:10, pages 2301.
Crossref
Stacia L. Koppenhafer, Kelli L. Goss, William W. Terry & David J. Gordon. (2020) Inhibition of the ATR–CHK1 Pathway in Ewing Sarcoma Cells Causes DNA Damage and Apoptosis via the CDK2-Mediated Degradation of RRM2. Molecular Cancer Research 18:1, pages 91-104.
Crossref
E. P. Shyam Shankar & Damodaran Bahulayan. (2019) Chemistry, chemical biology and photophysics of certain new chromene–triazole–coumarin triads as fluorescent inhibitors of CDK2 and CDK4 induced cancers. New Journal of Chemistry 43:35, pages 13863-13872.
Crossref
Shyam Shankar Eramangalam Puthumana & Bahulayan Damodaran. (2019) ICT‐Based Blue‐Emitting Dual‐Functional Probe (Ugi EML BLUE) for Bio‐Imaging and Cytotoxic Activities on HeLa Cells. ChemistrySelect 4:18, pages 5366-5374.
Crossref
Hui Xiao Chao, Randy I Fakhreddin, Hristo K Shimerov, Katarzyna M Kedziora, Rashmi J Kumar, Joanna Perez, Juanita C Limas, Gavin D Grant, Jeanette Gowen Cook, Gaorav P Gupta & Jeremy E Purvis. (2019) Evidence that the human cell cycle is a series of uncoupled, memoryless phases. Molecular Systems Biology 15:3.
Crossref
Yun-peng Yang, Li-ping He, Jing-xiao Bao, Yi-fei Qi & John Z. H. Zhang. (2019) Computational analysis for residue-specific CDK2-inhibitor bindings. Chinese Journal of Chemical Physics 32:1, pages 134-142.
Crossref
Mousumi Tania, Jakaria Shawon, Kazi Saif, Rudolf Kiefer, Mahdi Safaei Khorram, Mohammad A. Halim & Md. Asaduzzaman Khan. (2019) Cordycepin Downregulates Cdk-2 to Interfere with Cell Cycle and Increases Apoptosis by Generating ROS in Cervical Cancer Cells: in vitro and in silico Study. Current Cancer Drug Targets 19:2, pages 152-159.
Crossref
Yongmei Guo, Jian Gong, Binlin Shi, Xiaoyu Guo & Sumei Yan. (2018) Effects of selenium on selenoprotein synthesis and antioxidant parameters of bovine mammary epithelial cells. Czech Journal of Animal Science 63:8, pages 313-322.
Crossref
Ali Abroudi, Sandhya Samarasinghe & Don Kulasiri. (2017) A comprehensive complex systems approach to the study and analysis of mammalian cell cycle control system in the presence of DNA damage stress. Journal of Theoretical Biology 429, pages 204-228.
Crossref
Sangeeta Chauhan, M. Kasim Diril, Joanna H.S. Lee, Xavier Bisteau, Vanessa Manoharan, Deepak Adhikari, Chandrahas Koumar Ratnacaram, Baptiste Janela, Juliane Noffke, Florent Ginhoux, Vincenzo Coppola, Kui Liu, Lino Tessarollo & Philipp Kaldis. (2016) Cdk2 catalytic activity is essential for meiotic cell division in vivo . Biochemical Journal 473:18, pages 2783-2798.
Crossref
Hai-Feng Zhang, Abdulraheem Alshareef, Chengsheng Wu, Ji-Wei Jiao, Poul H. Sorensen, Raymond Lai, Li-Yan Xu & En-Min Li. (2016) miR-200b induces cell cycle arrest and represses cell growth in esophageal squamous cell carcinoma. Carcinogenesis 37:9, pages 858-869.
Crossref
James S. Blachly, John C. Byrd & Michael Grever. (2016) Cyclin-dependent kinase inhibitors for the treatment of chronic lymphocytic leukemia. Seminars in Oncology 43:2, pages 265-273.
Crossref
Dharmesh Kumar, Mahesh Sukapaka, G. D. Kiran Babu & Yogendra Padwad. (2015) Chemical Composition and In Vitro Cytotoxicity of Essential Oils from Leaves and Flowers of Callistemon citrinus from Western Himalayas. PLOS ONE 10:8, pages e0133823.
Crossref
N.Y. Rusetskaya & V.B. Borodulin. (2015) Biological activity of selenorganic compounds at heavy metal salts intoxication. Biomeditsinskaya Khimiya 61:4, pages 449-461.
Crossref
N. Y. Rusetskaya & V. B. Borodulin. (2015) Biological activity of organoselenium compounds in heavy metal intoxication. Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry 9:1, pages 45-57.
Crossref
Jin-Peng He, Yun Hao, Xiao-Lin Wang, Xiao-Jin Yang, Jing-Fan Shao, Feng-Jin Guo & Jie-Xiong Feng. (2014) Review of the Molecular Pathogenesis of Osteosarcoma. Asian Pacific Journal of Cancer Prevention 15:15, pages 5967-5976.
Crossref
Sena Yoon, Eunji Han, Young-Chul Choi, Honghwan Kee, Yongsu Jeong, Jaeseung Yoon & Kwanghee Baek. (2014) Inhibition of Cell Proliferation and Migration by miR-509-3p That Targets CDK2, Rac1, and PIK3C2A. Molecules and Cells 37:4, pages 314-321.
Crossref
Ranadip Mandal, Monika Raab, Yves Matthess, Sven Becker, Rainald Knecht & Klaus Strebhardt. (2014) pERK 1/2 inhibit Caspase-8 induced apoptosis in cancer cells by phosphorylating it in a cell cycle specific manner. Molecular Oncology 8:2, pages 232-249.
Crossref
Ade Kallas, Martin Pook, Annika Trei & Toivo Maimets. (2014) Assessment of the Potential of CDK2 Inhibitor NU6140 to Influence the Expression of Pluripotency Markers NANOG, OCT4, and SOX2 in 2102Ep and H9 Cells. International Journal of Cell Biology 2014, pages 1-16.
Crossref
Manvi Porwal, Sarah Cohen, Kenza Snoussi, Ruth Popa-Wagner, Fenja Anderson, Nathalie Dugot-Senant, Harald Wodrich, Christiane Dinsart, Jürgen A. Kleinschmidt, Nelly Panté & Michael Kann. (2013) Parvoviruses Cause Nuclear Envelope Breakdown by Activating Key Enzymes of Mitosis. PLoS Pathogens 9:10, pages e1003671.
Crossref
Huawei Zeng, Jay Cao & Gerald CombsJr.Jr.. (2013) Selenium in Bone Health: Roles in Antioxidant Protection and Cell Proliferation. Nutrients 5:1, pages 97-110.
Crossref
Denitra Breuer, Alexander Kotelkin, Tatiana Ammosova, Namita Kumari, Andrey Ivanov, Andrey V Ilatovskiy, Monique Beullens, Philip R Roane, Mathieu Bollen, Michael G Petukhov, Fatah Kashanchi & Sergei Nekhai. (2012) CDK2 Regulates HIV-1 Transcription by Phosphorylation of CDK9 on Serine 90. Retrovirology 9:1.
Crossref
Christine K. ChengW. Clay GustafsonElizabeth CharronBenjamin T. Houseman, Eli Zunder, Andrei GogaNathanael S. GrayBrian Pollok, Scott A. Oakes, C. David JamesKevan M. Shokat, William A. WeissQi-Wen Fan. (2012) Dual blockade of lipid and cyclin-dependent kinases induces synthetic lethality in malignant glioma. Proceedings of the National Academy of Sciences 109:31, pages 12722-12727.
Crossref
Yue Wang, Qiaomei Jin, Guowu Lin, Taotao Yang, Zhanwei Wang, Yi Lu, Yimin Tang, Lifang Liu & Tao Lu. (2012) Synthesis and Structure of the β-Carboline Derivatives and Their Binding Intensity with Cyclin-Dependent Kinase 2. Chemical and Pharmaceutical Bulletin 60:4, pages 435-441.
Crossref
Tien-Chun Wang, Chih-Nan Fang, Chih-Chien Shen, Hui-Yu Wei, Yui-Ping Weng, Jung-Yaw Lin, Hsiu Mei Hsieh-Li & Chen-Yu Lee. (2012) Yang-Dan-Tang, Identified from 15 Chinese Herbal Formulae, Inhibits Human Lung Cancer Cell Proliferation via Cell Cycle Arrest. Evidence-Based Complementary and Alternative Medicine 2012, pages 1-12.
Crossref
Yi Chang, Yih-Huei Uen, Chang-Chih Chen, Song-Chow Lin, Shiao-Yun Tseng, Yi-Hsuan Wang, Joen-Rong Sheu & Cheng-Ying Hsieh. (2011) Platonin inhibited PDGF-BB-induced proliferation of rat vascular smooth muscle cells via JNK1/2-dependent signaling. Acta Pharmacologica Sinica 32:11, pages 1337-1344.
Crossref
Huw D. Thomas, Lan-Zhen Wang, Celine Roche, Johanne Bentley, Yuzhu Cheng, Ian R. Hardcastle, Bernard T. Golding, Roger J. Griffin, Nicola J. Curtin & David R. Newell. (2011) Preclinical in vitro and in vivo evaluation of the potent and specific cyclin-dependent kinase 2 inhibitor NU6102 and a water soluble prodrug NU6301. European Journal of Cancer 47:13, pages 2052-2059.
Crossref
Rui-Qing Tian, Xing-Hua Wang, Li-Juan Hou, Wei-Hua Jia, Qian Yang, Yi-Xuan Li, Min Liu, Xin Li & Hua Tang. (2011) MicroRNA-372 Is Down-regulated and Targets Cyclin-dependent Kinase 2 (CDK2) and Cyclin A1 in Human Cervical Cancer, Which May Contribute to Tumorigenesis. Journal of Biological Chemistry 286:29, pages 25556-25563.
Crossref
Karl A. Merrick, Lara Wohlbold, Chao Zhang, Jasmina J. Allen, Dai Horiuchi, Noelle E. Huskey, Andrei Goga, Kevan M. Shokat & Robert P. Fisher. (2011) Switching Cdk2 On or Off with Small Molecules to Reveal Requirements in Human Cell Proliferation. Molecular Cell 42:5, pages 624-636.
Crossref
Courtney R LaValle, Karla Bravo-Altamirano, Karthik V Giridhar, Jun Chen, Elizabeth Sharlow, John S Lazo, Peter Wipf & Q Jane Wang. (2010) Novel protein kinase D inhibitors cause potent arrest in prostate cancer cell growth and motility. BMC Chemical Biology 10:1.
Crossref
Kamil Paruch, Michael P. Dwyer, Carmen Alvarez, Courtney Brown, Tin-Yau Chan, Ronald J. Doll, Kerry Keertikar, Chad Knutson, Brian McKittrick, Jocelyn Rivera, Randall Rossman, Greg Tucker, Thierry Fischmann, Alan Hruza, Vincent Madison, Amin A. Nomeir, Yaolin Wang, Paul Kirschmeier, Emma Lees, David Parry, Nicole Sgambellone, Wolfgang Seghezzi, Lesley Schultz, Frances Shanahan, Derek Wiswell, Xiaoying Xu, Quiao Zhou, Ray A. James, Vidyadhar M. Paradkar, Haengsoon Park, Laura R. Rokosz, Tara M. Stauffer & Timothy J. Guzi. (2010) Discovery of Dinaciclib (SCH 727965): A Potent and Selective Inhibitor of Cyclin-Dependent Kinases. ACS Medicinal Chemistry Letters 1:5, pages 204-208.
Crossref
David Parry, Timothy Guzi, Frances Shanahan, Nicole Davis, Deepa Prabhavalkar, Derek Wiswell, Wolfgang Seghezzi, Kamil Paruch, Michael P. Dwyer, Ronald Doll, Amin Nomeir, William Windsor, Thierry Fischmann, Yaolin Wang, Martin Oft, Taiying Chen, Paul Kirschmeier & Emma M. Lees. (2010) Dinaciclib (SCH 727965), a Novel and Potent Cyclin-Dependent Kinase Inhibitor. Molecular Cancer Therapeutics 9:8, pages 2344-2353.
Crossref
Oleg Timofeev, Onur Cizmecioglu, Florian Settele, Tore Kempf & Ingrid Hoffmann. (2010) Cdc25 Phosphatases Are Required for Timely Assembly of CDK1-Cyclin B at the G2/M Transition. Journal of Biological Chemistry 285:22, pages 16978-16990.
Crossref
Omar FloresZhengying WangKaren E. Knudsen & Kerry L. Burnstein. (2010) Nuclear Targeting of Cyclin-Dependent Kinase 2 Reveals Essential Roles of Cyclin-Dependent Kinase 2 Localization and Cyclin E in Vitamin D-Mediated Growth Inhibition. Endocrinology 151:3, pages 896-908.
Crossref
Ling Xue, Yuefang Sun, Leslie Chiang, Bo He, Chulho Kang, Hector Nolla & Astar Winoto. (2010) Coupling of the Cell Cycle and Apoptotic Machineries in Developing T Cells. Journal of Biological Chemistry 285:10, pages 7556-7565.
Crossref
Robert P. Fisher. 2010. Genome Stability and Human Diseases. Genome Stability and Human Diseases 1 15 .
Jian Kuang & Ruoning Wang. 2009. Checkpoint Controls and Targets in Cancer Therapy. Checkpoint Controls and Targets in Cancer Therapy 37 51 .
Neil Johnson & Geoffrey I. Shapiro. 2010. Cell Cycle Deregulation in Cancer. Cell Cycle Deregulation in Cancer 167 185 .
Amelie Boquoi, Tina Chen & Greg H. Enders. (2009) Chemoprevention of Mouse Intestinal Tumorigenesis by the Cyclin-Dependent Kinase Inhibitor SNS-032. Cancer Prevention Research 2:9, pages 800-806.
Crossref
Kate F. Byth, Andrew Thomas, Gareth Hughes, Cheryl Forder, Alexandra McGregor, Catherine Geh, Sandra Oakes, Clive Green, Mike Walker, Nicholas Newcombe, Stephen Green, Jim Growcott, Andy Barker & Robert W. Wilkinson. (2009) AZD5438, a potent oral inhibitor of cyclin-dependent kinases 1, 2, and 9, leads to pharmacodynamic changes and potent antitumor effects in human tumor xenografts. Molecular Cancer Therapeutics 8:7, pages 1856-1866.
Crossref
Huawei Zeng. (2009) Selenium as an Essential Micronutrient: Roles in Cell Cycle and Apoptosis. Molecules 14:3, pages 1263-1278.
Crossref
Zhiqin Wang, Yitao Qi, Qian Chen, Di Yang, Shusheng Tang, Xi Jin, Jie Gao, Juanling Fu, Zongcan Zhou, Jie Wang & Xilong Xiao. (2009) Cyclin A is essential for the p53-modulated inhibition from benzo(a)pyrene toxicity in A549 cells. Toxicology 256:1-2, pages 1-6.
Crossref
Malcolm Anderson, David M. Andrews, Andy J. Barker, Claire A. Brassington, Jason Breed, Kate F. Byth, Janet D. Culshaw, M. Raymond V. Finlay, Eric Fisher, Helen H.J. McMiken, Clive P. Green, Dave W. Heaton, Ian A. Nash, Nicholas J. Newcombe, Sandra E. Oakes, Richard A. Pauptit, Andrew Roberts, Judith J. Stanway, Andrew P. Thomas, Julie A. Tucker, Mike Walker & Hazel M. Weir. (2008) Imidazoles: SAR and development of a potent class of cyclin-dependent kinase inhibitors. Bioorganic & Medicinal Chemistry Letters 18:20, pages 5487-5492.
Crossref
Pedro Rodriguez-Collazo, Sara K. Snyder, Rebecca C. Chiffer, Erin A. Bressler, Ty C. Voss, Eric P. Anderson, Hans-Gottfried Genieser & Catharine L. Smith. (2008) cAMP signaling regulates histone H3 phosphorylation and mitotic entry through a disruption of G2 progression. Experimental Cell Research 314:15, pages 2855-2869.
Crossref
L De Boer, V Oakes, H Beamish, N Giles, F Stevens, M Somodevilla-Torres, C DeSouza & B Gabrielli. (2008) Cyclin A/cdk2 coordinates centrosomal and nuclear mitotic events. Oncogene 27:31, pages 4261-4268.
Crossref
Anna Pezzotta, Marilena Mister, Giuseppe Monteferrante, Linda Cassis, Nadia Azzollini, Sistiana Aiello, Maddalena Satta, Ariela Benigni, Giuseppe Remuzzi & Marina Noris. (2008) Effect of Seliciclib (CYC202, R-Roscovitine) on Lymphocyte Alloreactivity and Acute Kidney Allograft Rejection in Rat. Transplantation 85:10, pages 1476-1482.
Crossref
Mohamed Salah I Abaza, Abdul-Majeed A Bahman & Rajaa J Al-Attiyah. (2008) Roscovitine synergizes with conventional chemo-therapeutic drugs to induce efficient apoptosis of human colorectal cancer cells. World Journal of Gastroenterology 14:33, pages 5162.
Crossref
A C Rigas, C N Robson & N J Curtin. (2007) Therapeutic potential of CDK inhibitor NU2058 in androgen-independent prostate cancer. Oncogene 26:55, pages 7611-7619.
Crossref
Maria Gabriella Brasca, Clara Albanese, Raffaella Amici, Dario Ballinari, Luca Corti, Valter Croci, Daniele Fancelli, Francesco Fiorentini, Marcella Nesi, Paolo Orsini, Fabrizio Orzi, Wilma Pastori, Ettore Perrone, Enrico Pesenti, Paolo Pevarello, Federico Riccardi-Sirtori, Fulvia Roletto, Patrick Roussel, Mario Varasi, Anna Vulpetti & Ciro Mercurio. (2007) 6-Substituted Pyrrolo[3,4-c]pyrazoles: An Improved Class of CDK2 Inhibitors. ChemMedChem 2:6, pages 841-852.
Crossref
Tsz Kan Fung, Hoi Tang Ma & Randy Y.C. Poon. (2007) Specialized Roles of the Two Mitotic Cyclins in Somatic Cells: Cyclin A as an Activator of M Phase–promoting Factor. Molecular Biology of the Cell 18:5, pages 1861-1873.
Crossref
Randy Poon & Tsz Kan Fung. (2007) Cyclin A2. AfCS-Nature Molecule Pages.
Crossref
John Hunt. 2006. Inhibitors of Cyclin-dependent Kinases as Anti-tumor Agents. Inhibitors of Cyclin-dependent Kinases as Anti-tumor Agents 251 264 .
Dongpo Cai, Vaughan M. LathamJr.Jr., Xinxin Zhang & Geoffrey I. Shapiro. (2006) Combined Depletion of Cell Cycle and Transcriptional Cyclin-Dependent Kinase Activities Induces Apoptosis in Cancer Cells. Cancer Research 66:18, pages 9270-9280.
Crossref
Mohammad R. Salabat, Xian Z. Ding, Jan B. Flesche, Micheal B. Ujiki, Tyler P. Robin, Mark S. Talamonti, Richard H. Bell & Thomas E. Adrian. (2006) On the Mechanisms of 12-Otetradecanoylphorbol-13-acetate-induced Growth Arrest in Pancreatic Cancer Cells. Pancreas 33:2, pages 148-155.
Crossref
Emma E. Furth, Karen S. Gustafson, Charlotte Y. Dai, Steven L. Gibson, Paul Menard-Katcher, Tina Chen, Jim Koh & Greg H. Enders. (2006) Induction of the Tumor-Suppressor p16INK4a within Regenerative Epithelial Crypts in Ulcerative Colitis. Neoplasia 8:6, pages 429-436.
Crossref
Geoffrey I. Shapiro. (2006) Cyclin-Dependent Kinase Pathways As Targets for Cancer Treatment. Journal of Clinical Oncology 24:11, pages 1770-1783.
Crossref
Greg H. Enders & Shannon L. Maude. (2006) Traffic safety for the cell: Influence of cyclin-dependent kinase activity on genomic stability. Gene 371:1, pages 1-6.
Crossref
Kate F. Byth, Catherine Geh, Cheryl L. Forder, Sandra E. Oakes & Andrew P. Thomas. (2006) The cellular phenotype of AZ703, a novel selective imidazo[1,2- a ]pyridine cyclin-dependent kinase inhibitor . Molecular Cancer Therapeutics 5:3, pages 655-664.
Crossref
Dongpo Cai, Kate F. Byth & Geoffrey I. Shapiro. (2006) AZ703, an Imidazo[1,2- a ]Pyridine Inhibitor of Cyclin-Dependent Kinases 1 and 2, Induces E2F-1-Dependent Apoptosis Enhanced by Depletion of Cyclin-Dependent Kinase 9 . Cancer Research 66:1, pages 435-444.
Crossref
Elvira Crescenzi, Giuseppe Palumbo & Hugh J.M. Brady. (2005) Roscovitine Modulates DNA Repair and Senescence: Implications for Combination Chemotherapy. Clinical Cancer Research 11:22, pages 8158-8171.
Crossref
Takeshi Takahashi, Fumiyuki Yamasaki, Tamotsu Sudo, Hiroaki Itamochi, Susumu Adachi, Mimi Tamamori-Adachi & Naoto T. Ueno. (2005) Cyclin A–associated kinase activity is needed for paclitaxel sensitivity. Molecular Cancer Therapeutics 4:7, pages 1039-1046.
Crossref
Florence I. Raynaud, Steven R. Whittaker, Peter M. Fischer, Steven McClue, Michael I. Walton, S. Elaine Barrie, Michelle D. Garrett, Paul Rogers, Simon J. Clarke, Lloyd R. Kelland, Melanie Valenti, Lisa Brunton, Suzanne Eccles, David P. Lane & Paul Workman. (2005) In vitro and In vivo Pharmacokinetic-Pharmacodynamic Relationships for the Trisubstituted Aminopurine Cyclin-Dependent Kinase Inhibitors Olomoucine, Bohemine and CYC202 . Clinical Cancer Research 11:13, pages 4875-4887.
Crossref
Vinicio Carloni, Francesco Vizzutti & Pietro Pantaleo. (2005) Farnesyltransferase Inhibitor, ABT-100, Is a Potent Liver Cancer Chemopreventive Agent. Clinical Cancer Research 11:11, pages 4266-4274.
Crossref
Shannon L. Maude & Greg H. Enders. (2005) Cdk Inhibition in Human Cells Compromises Chk1 Function and Activates a DNA Damage Response. Cancer Research 65:3, pages 780-786.
Crossref
Kate F Byth, Janet D Culshaw, Stephen Green, Sandra E Oakes & Andrew P Thomas. (2004) Imidazo[1,2- a ]pyridines. Part 2 : SAR and optimisation of a potent and selective class of cyclin-dependent kinase inhibitors. Bioorganic & Medicinal Chemistry Letters 14:9, pages 2245-2248.
Crossref
Jayashree Mitra & Greg H Enders. (2004) Cyclin A/Cdk2 complexes regulate activation of Cdk1 and Cdc25 phosphatases in human cells. Oncogene 23:19, pages 3361-3367.
Crossref
Kin-Chun Luk, Mary Ellen Simcox, Andy Schutt, Karen Rowan, Thelma Thompson, Yi Chen, Ursula Kammlott, Wanda DePinto, Pete Dunten & Apos Dermatakis. (2004) A new series of potent oxindole inhibitors of CDK2. Bioorganic & Medicinal Chemistry Letters 14:4, pages 913-917.
Crossref
Steven R. Whittaker, Mike I. Walton, Michelle D. Garrett & Paul Workman. (2004) The Cyclin-dependent Kinase Inhibitor CYC202 ( R -Roscovitine) Inhibits Retinoblastoma Protein Phosphorylation, Causes Loss of Cyclin D1, and Activates the Mitogen-activated Protein Kinase Pathway . Cancer Research 64:1, pages 262-272.
Crossref
Cyril Berthet, Eiman Aleem, Vincenzo Coppola, Lino Tessarollo & Philipp Kaldis. (2003) Cdk2 Knockout Mice Are Viable. Current Biology 13:20, pages 1775-1785.
Crossref
John Lynch, Matthew Keller, Rong-Jun Guo, Donald Yang & Peter Traber. (2003) Cdx1 inhibits the proliferation of human colon cancer cells by reducing cyclin D1 gene expression. Oncogene 22:41, pages 6395-6407.
Crossref
Sagrario Ortega, Ignacio Prieto, Junko Odajima, Alberto Martín, Pierre Dubus, Rocio Sotillo, Jose Luis Barbero, Marcos Malumbres & Mariano Barbacid. (2003) Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice. Nature Genetics 35:1, pages 25-31.
Crossref
Osamu Tetsu & Frank McCormick. (2003) Proliferation of cancer cells despite CDK2 inhibition. Cancer Cell 3:3, pages 233-245.
Crossref
Antonio Mazzocca, Sabrina Giusti, Andrew D. Hamilton, Said M. Sebti, Pietro Pantaleo & Vinicio Carloni. (2003) Growth Inhibition by the Farnesyltransferase Inhibitor FTI-277 Involves Bcl-2 Expression and Defective Association with Raf-1 in Liver Cancer Cell Lines. Molecular Pharmacology 63:1, pages 159-166.
Crossref
Jonathan D. Moore, Sally Kornbluth & Tim Hunt. (2002) Identification of the Nuclear Localization Signal in Xenopus Cyclin E and Analysis of Its Role in Replication and Mitosis . Molecular Biology of the Cell 13:12, pages 4388-4400.
Crossref
Elaine Stead, Josephine White, Renate Faast, Simon Conn, Sherilyn Goldstone, Joy Rathjen, Urvashi Dhingra, Peter Rathjen, Duncan Walker & Stephen Dalton. (2002) Pluripotent cell division cycles are driven by ectopic Cdk2, cyclin A/E and E2F activities. Oncogene 21:54, pages 8320-8333.
Crossref
Greg H Enders. (2002) Cyclins in breast cancer: too much of a good thing. Breast Cancer Research 4:4.
Crossref
Huawei Zeng. (2002) Selenite and Selenomethionine Promote HL-60 Cell Cycle Progression. The Journal of Nutrition 132:4, pages 674-679.
Crossref
Scott Wadler. (2001) Perspectives for cancer therapies with cdk2 inhibitors. Drug Resistance Updates 4:6, pages 347-367.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.